Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Quality Improvement Vaccines Italy 2026 VAC US SMFM Maternal RSV QIRelease Date:Partner: Society for Maternal Fetal MedicineQuality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipEducation Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate CancerRelease Date:Education Oncology All Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Title Grant Type Focus Area Country Application Due Date Knowledge Gaps in the Clinical and Epidemiological Characteristics of RSVRelease Date:Education Vaccines USA Rapid Education on COVID-19 Outpatient TreatmentRelease Date:Education Hospital USA Real World Evidence for CDK 4/6 inhibitors in Shared Clinical Decision MakingRelease Date:Education Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA 2022/2023 Global COVID-19 ASPIRERelease Date:Research Hospital All Engaging the Patient Community in Research and Publications (USA, Canada, Europe)Education Hospital All Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel DiseaseQuality Improvement Inflammation & Immunology Japan Optimizing Canadian Telehealth Use for Women’s HealthRelease Date:Quality Improvement Internal Medicine Canada Gene Therapy Site-Preparedness Competitive Grant ProgramRelease Date:Partner: International Pharmaceutical Federation (FIP)Quality Improvement Rare Disease All Call for Independent Quality Improvement Grant Applications Oncology – Prostate CancerQuality Improvement Oncology USA Global Hemophilia Grant - Equity in Therapeutic Patient EducationRelease Date:Review Process: Expert Review PanelEducation Rare Disease All Gene and Gene-modified Cell Therapies Medical EducationRelease Date:Partner: American Society of Gene + Cell TherapyEducation Rare Disease All